Advertisement

Topics

Lilly to Use Topas Platform in Immunology Collaboration

05:27 EDT 22 Aug 2017 | Genetic Engineering News

Eli Lilly will use Topas Therapeutics’ antigen-specific tolerance induction platform to develop new treatments, with an initial focus on external antigens believed to induce inflammation and/or autoimmune disease, Topas said today. The companies have signed a multi-year research and option agreement whose value was not disclosed. Topas did say, however, that it will receive from Lilly R&D funding and payments tied to unspecified “future success” of compounds to be in-licensed by Lilly. The pharma giant has been granted an option for all candidates produced under the collaboration for in-licensing and further development, while Topas has agreed to conduct pre-clinical proof-of-principle studies with Lilly to generate the drug candidates. Topas says its platform is designed to induce antigen-specific immune tolerance by harnessing the liver's natural immunology capabilities. Through the platform, peptide-loaded nanoparticles are selectively targeted towards liver sinusoidal endothelial cells (LSECs), where tolerance against bloodborne antigens is ...

Original Article: Lilly to Use Topas Platform in Immunology Collaboration

NEXT ARTICLE

More From BioPortfolio on "Lilly to Use Topas Platform in Immunology Collaboration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...